6DECEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comToday, contract research organisations (CROs) are among the most critical growth sectors of the pharmaceutical industry, with many firms experiencing double-digit annual growth. This growth is driven by the trend of increased outsourcing by pharmaceutical and biotechnology companies that are looking to shift from fixed to a variable cost model and access specialist capabilities. CROs have also become one of the most active sectors for mergers and acquisitions, with larger players consolidating to offer more comprehensive service offerings.However, over the next few years, major pharmaceutical companies are expected to shift from a transactional outsourcing relationship to a more strategic relationship-based model for biologics, manufacturing capacity, and data-driven clinical innovation. Clear communication and transparency will become paramount, and technology will bestow them with the power of better decision making in real-time. Advanced technologies such as AI, ML, and IoT will be taking knowledge management in the pharma industry to the next level, and new visualisation tools will make data interpretation much easier. In this edition of Pharma Tech Outlook, we bring you the story of some of the most prominent organisations specialising in CRO consulting/service companies in Europe and UK, which are significant drivers of key trends and strategies. Besides, the magazine also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing a CRO solution provider according to your requirements.Let us know your thoughts!The Changing Dynamics of CRO FirmsCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 01 - 2020, Vol 06 - Issue 28 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerChris LynnEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >